Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
about
Haemolytic disease of the fetus and newborn.Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis.Intravenous Immunoglobulin G Treatment in ABO Hemolytic Disease of the Newborn, is it Myth or Real?Improving the management and outcome in haemolytic disease of the foetus and newborn.Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.
P2860
Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Early intravenous immunoglobin ...... e randomized controlled trial.
@en
Early intravenous immunoglobin
@nl
type
label
Early intravenous immunoglobin ...... e randomized controlled trial.
@en
Early intravenous immunoglobin
@nl
prefLabel
Early intravenous immunoglobin ...... e randomized controlled trial.
@en
Early intravenous immunoglobin
@nl
P2860
P1476
Early intravenous immunoglobin ...... ve randomized controlled trial
@en
P2093
Heba Wegdan Abaza
Mohsen Saleh Elalfy
P2860
P2888
P304
P356
10.1007/S00431-010-1310-8
P577
2010-10-06T00:00:00Z